Work backward, and Vertiv is effectively saying it expects UIG to produce about $110 million of EBITDA in 2027. And for the full $2.6 billion price to work out to less than 13 times EBITDA, UIG's ...

Karman is a relatively new arrival to the stock exchange, and it's already had its share of negative news; last week, for ...

Is Circle Internet's rally built to last? New trust charters helped the stock take off, but its valuation still raises ...

While Nvidia's aggressive progress in the server CPU market doesn't bode well for Intel and AMD, it is indeed good news for ...

The disappointing results come at an especially bad time for Lululemon, as it's getting set to welcome a new CEO, Heidi O'Neill, a longtime Nike exec who joins the company after it was run for seven ...

On Aug. 18, the U.S. Space Force picked Rocket Lab to join its Space Data Network Consortium, awarding the company $12 ...

The most recent official market correction happened last year when President Trump announced new tariffs. There haven't been ...

A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history.

Highly specialized medical device maker MiniMed Group ( MMED +0.34%) was highly prized by investors over the past few trading ...

The courtroom win preserves a corner of the ad empire that was already in decline. What exactly did the company protect?

Both companies are unprofitable with sky-high valuations, but they are now seeing more than 30% year-over-year sales growth.

However, analysts tracking Phreesia stock were expecting an even higher bounce. Their consensus estimate for net profit was $0.09 per share. On the top line, the company edged past the average pundit ...